Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Aug;22(8):1464-72.
doi: 10.1021/tx9001572.

The influence of repair pathways on the cytotoxicity and mutagenicity induced by the pyridyloxobutylation pathway of tobacco-specific nitrosamines

Affiliations

The influence of repair pathways on the cytotoxicity and mutagenicity induced by the pyridyloxobutylation pathway of tobacco-specific nitrosamines

Li Li et al. Chem Res Toxicol. 2009 Aug.

Abstract

Tobacco-specific nitrosamines, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and N'-nitrosonornicotine, are considered to be human carcinogens. Both compounds are metabolized to pyridyloxobutylating intermediates that react with DNA to form adducts such as 7-[4-(3-pyridyl)-4-oxobut-1-yl]guanine, O(2)-[4-(3-pyridyl)-4-oxobut-1-yl]cytosine, O(2)-[4-(3-pyridyl)-4-oxobut-1-yl]-2'-deoxythymidine (O(2)-pobdT), O(6)-[4-(3-pyridyl)-4-oxobut-1-yl]-2'-deoxyguanosine (O(6)-pobdG), and 4-hydroxy-1-(3-pyridyl)-1-butanone-releasing adducts. The role of specific DNA adducts in the overall genotoxic activity of the pyridyloxobutylation pathway is not known. One adduct, O(6)-pobdG, is mutagenic. To characterize the mutagenic and cytotoxic properties of pyridyloxobutyl DNA adducts, the impact of DNA repair pathways on the cytotoxic and mutagenic properties of the model pyridyloxobutylating agent, 4-(acetoxymethylnitrosamino)-1-(3-pyridyl)-1-butanone (NNKOAc), was investigated in Chinese hamster ovary cell lines proficient or deficient in O(6)-alkylguanine DNA alkyltransferase (AGT), deficient in both AGT and base excision repair (BER), or deficient in both AGT and nucleotide excision repair (NER). The repair of the four pyridyloxobutyl DNA adducts was determined in the same cell lines via sensitive LC-MS/MS methods. NNKOAc was more cytotoxic in the cell lines lacking AGT, BER, and NER repair pathways. It also induced more mutations in the hprt gene in the BER- and NER-deficient cell lines. However, AGT expression did not influence NNKOAc's mutagenicity despite efficient repair of O(6)-pobdG. Analysis of the hprt mutational spectra indicated that NNKOAc primarily caused point mutations at AT base pairs. GC to AT transition mutations were a minor contributor to the overall mutation spectrum, providing a rationale for the observation that AGT does not protect against the overall mutagenic properties of NNKOAc in this model system. The only adduct affected by the absence of effective NER was O(2)-pobdT. Slower repair of O(2)-pobdT in NER-deficient cells was associated with increased AT to TA transversion mutations, supporting the hypothesis that these mutations are caused by O(2)-pobdT. Together, these data support a hypothesis that the pyridyloxobutylation pathway generates multiple mutagenic and toxic adducts.

PubMed Disclaimer

Figures

Figure 1
Figure 1
A. Proposed activation pathways for NNN, NNK and NNKOAc. B. Structures of characterized pyridyloxobutyl DNA adducts.
Figure 2
Figure 2. Cytotoxicity (A, C) and hprt mutagenic activity (B, D) in CHO cell lines following a 1 h treatment with increasing concentrations of NNKOAc
The values represent the average of four separate experiments. The error bars represent the standard deviation. AA8: normal NER, no AGT; UV5: deficient in NER, no AGT; EM9: deficient in XRCC1 (BER), no AGT; CHOpcDNA3: empty vector; CHOAGT: vector containing hAGT. * indicates that the treated cell lines were statistically significantly different from the parent cell lines at that concentration, p < 0.05.
Figure 3
Figure 3. Initial levels of pyridyloxobutyl DNA adducts in CHO cell lines following a 1 h treatment with 32 μM NNKOAc
The values represent averages of 3 replicates. The error bars represent the standard deviation. AA8: normal NER, no AGT; UV5: deficient in NER, no AGT; CHOpcDNA3: empty vector; CHOAGT: vector containing hAGT. Adduct levels were determined by LC-MS/MS analysis of enzymatic hydrolysates of DNA isolated from NNKOAc-treated CHO cell lines.
Figure 4
Figure 4. Time course of adduct repair following a 1 h exposure to 8 μM NNKOAc
The values equal the average of 3–5 replicates. The error bars represent the standard deviation. Adduct levels are normalized relative to the dG (O2-pobC, 7-pobG, O2-pobdT and O6-pobdG) or G (O6-pobG) concentrations in the enzyme or acid hydrolysates, respectively. AA8: normal NER, no AGT; UV5: deficient in NER, no AGT; EM9: deficient in XRCC1 (BER), no AGT; CHOpcDNA3: empty vector; CHOAGT: vector containing hAGT. * indicates that the treated cell lines were statistically significantly different from the parent cell lines at that concentration, p < 0.05.
Figure 5
Figure 5. Excision of O6-pobdG adduct by human repair factors
Substrate DNA (0.8 nM) was incubated with RPA (140 nM), XPA (65 nM), XPC•hR23B (5 nM), TFIIH (~ 12 nM), XPF•ERCC1 (4 nM), and XPG (3 nM) for 2 h at 30°C. DNA alone (lanes 1, 3, 5) and complete reactions (lanes 2, 4, 6) are shown for undamaged DNA (lanes 1–2), O6-pobdG DNA (lanes 3–4), and T[6-4]T photoproduct (lanes 5–6). Brackets indicate excision products visualized by autoradiography after resolution in 10% sequencing gel. Levels of excision in this experiment were 0.8% (UM), 1.1% (O6-pobdG), and 32.7% T[6-4]T.

Similar articles

Cited by

References

    1. Hecht SS. Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines. Chem Res Toxicol. 1998;11:560–603. - PubMed
    1. Hecht SS. Tobacco smoke carcinogens and lung cancer. J Natl Cancer Instit. 1999;91:1194–1210. - PubMed
    1. Hecht SS, Spratt TE, Trushin N. Evidence for 4-(3-pyridyl)-4-oxobutylation of DNA in F344 rats treated with the tobacco specific nitrosamines 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and N′-nitrosonornicotine. Carcinogenesis. 1988;9:161–165. - PubMed
    1. Peterson LA, Hecht SS. O6-Methylguanine is a critical determinant of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone tumorigenesis in A/J mouse lung. Cancer Res. 1991;51:5557–5564. - PubMed
    1. Wang M, Cheng G, Sturla SJ, McIntee EJ, Villalta PW, Upadhyaya P, Hecht SS. Identification of adducts formed by pyridyloxobutylation of deoxyguanosine and DNA by 4-(acetoxymethylnitrosamino)-1-(3-pyridyl)-1-butanone, a chemically activated form of tobacco specific carcinogens. Chem Res Toxicol. 2003;16:616–626. - PubMed

Publication types